ストックスクリーナーアプリを入手
1.45
0.69%
0.01
アフターアワーズ：
1.45
前日終値:
$1.44
開ける：
$1.445
24時間の取引高:
1.33M
Relative Volume:
0.34
時価総額：
$4.77M
収益：
$12.99M
当期純損益:
$-23.72M
株価収益率:
-0.0149
EPS:
-97.2514
ネットキャッシュフロー:
$-23.28M
1週間 パフォーマンス:
-11.59%
1か月 パフォーマンス:
-11.59%
6か月 パフォーマンス:
-93.75%
1年 パフォーマンス:
-98.91%
1日の値動き範囲:
$1.42
$1.48
1週間の範囲:
$1.42
$1.8302
52週間の値動き範囲:
$1.32
$381.10
Aptevo Therapeutics Inc Stock (APVO) Company Profile
APVO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.45 | 4.73M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-11-05 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-10-05 | 再開されました | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc (APVO) 最新ニュース
Will Aptevo Therapeutics Inc. stock outperform international peersJuly 2025 Setups & Fast Entry High Yield Tips - newser.com
Real time breakdown of Aptevo Therapeutics Inc. stock performanceJuly 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Advanced analytics toolkit walkthrough for Aptevo Therapeutics Inc.Market Risk Report & Reliable Volume Spike Alerts - newser.com
What drives APLM stock priceMarket Rumors and News & View Live Stock Forecasts Instantly - Early Times
Is Aptevo Therapeutics Inc. (AP81) stock inflation resilient2025 Trade Ideas & Technical Buy Zone Confirmations - newser.com
Why analysts raise outlook for Aptevo Therapeutics Inc. (AP81) stock2025 Major Catalysts & High Yield Equity Trading Tips - newser.com
Will Aptevo Therapeutics Inc. stock recover faster than marketPortfolio Risk Summary & Real-Time Sentiment Analysis - newser.com
Aptevo Participating in the BIO International Convention - ACCESS Newswire
Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Livingston Daily
Earnings Report: What drives Aptevo Therapeutics Incs stock priceJuly 2025 Intraday Action & Weekly Sector Rotation Insights - خودرو بانک
Price Action: What is Aptevo Therapeutics Incs 5 year growth outlookWeekly Trading Summary & Growth Focused Entry Reports - khodrobank.com
Entry Recap: Is NWPX trading at a discountSwing Trade & Technical Entry and Exit Alerts - khodrobank.com
Insider Sell: Is Aptevo Therapeutics Inc. stock trending bullishTrade Ideas & High Accuracy Trade Signal Alerts - خودرو بانک
Dividend Watch: Is Aptevo Therapeutics Inc a defensive stockTrade Risk Summary & Weekly High Momentum Picks - خودرو بانک
Profit Recap: Is Aptevo Therapeutics Inc impacted by rising ratesTrade Exit Report & Fast Moving Stock Watchlists - خودرو بانک
Aptevo Therapeutics Stock Plummets to New 52-Week Low of $1.32 - Markets Mojo
Block Trades: What is Aptevo Therapeutics Inc. s 5 year growth outlook2025 Buyback Activity & Precise Trade Entry Recommendations - khodrobank.com
Options Flow: Does Aptevo Therapeutics Inc. offer margin of safety2025 Market Trends & Weekly Chart Analysis and Guides - خودرو بانک
Bull Bear: Can Aptevo Therapeutics Inc navigate macro headwinds2025 Trade Ideas & Fast Exit/Entry Strategy Plans - خودرو بانک
FOMO Trade: How liquid is Aptevo Therapeutics Inc stockQuarterly Market Summary & AI Enhanced Trading Alerts - خودرو بانک
Why Is Aptevo Therapeutics Stock (APVO) Up 85% Today? - TipRanks
Aptevo Therapeutics: Surprising Results in AML Trial! - StocksToTrade
Nasdaq Surges 100 Points; US Initial Jobless Claims Fall - Benzinga
Morning Market Movers: ETNB, APVO, PBM, BEEM See Big Swings - RTTNews
Intel, Nike, Aptevo - TradingView
Aptevo soars after billionaire investor discloses stake - TradingView
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Aptevo Therapeutics Surges Over 46% After Hours On Breakthrough AML Treatment Results - Benzinga
Biotech Stocks To Add to Your WatchlistSeptember 16th - MarketBeat
Tech Rally: Does RANG outperform in volatile marketsM&A Rumor & Long-Term Safe Investment Plans - خودرو بانک
Aug Closing: How do insiders feel about Bleichroeder Acquisition Corp. IWeekly Profit Recap & Low Drawdown Trading Strategies - خودرو بانک
Aptevo says mipletamig deliver 100% remission rate in RAINIER cohort 3 - TipRanks
Aptevo Announces 100% Remission in AML Trial - TipRanks
Insider Trends: Whats next for Aptevo Therapeutics Inc stockWeekly Stock Recap & Community Supported Trade Ideas - خودرو بانک
Aptevo Therapeutics Inc. Announces Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINier Trial for AML - MarketScreener
APVO Stock Surge: A Time to Consider? - timothysykes.com
Why Is Aptevo Therapeutics Stock (APVO) Up 50% Today? - TipRanks
Aptevo Therapeutics Stock Rallies On 100% Remission Rate In Acute Myeloid Leukemia Trial Cohort - Stocktwits
Sentiment Recap: Is Aptevo Therapeutics Inc stock a value trap2025 Volatility Report & Fast Moving Stock Watchlists - خودرو بانک
APVO Stock Jumps over 4%: Why Aptevo (APVO) Stock Is Trading Higher Today? - Markets.com
Aug Closing: Is Rithm Property Trust Inc. forming a breakout pattern2025 Institutional Moves & Expert Curated Trade Setup Alerts - خودرو بانک
Ark, Atom file to go public in Hong Kong; Aptevo’s stock rallies on AML data - Endpoints News
Aptevo Therapeutics Shares Soar Following 100% Remission Rate in AML Trial - MSN
Aptevo jumps after blood cancer therapy shows 100% remission in trial - TradingView
Aptevo Therapeutics Hits New 52-Week Low at $1.41 - Markets Mojo
Aptevo Therapeutics stock soars after 100% remission rate in AML trial - Investing.com UK
Aptevo Therapeutics Inc (APVO) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):